N-(5-(((5-(tert-butyl)oxazol-2-yl)methyl)thio)thiazol-2-yl)-1-((2-(2-(2-(((1R,2S,5R)-2-isopropyl-5-methylcyclohexyl)oxy)acetamido)ethoxy)ethyl)sulfonyl)piperidine-4-carboxamide

ID: ALA5175399

Chembl Id: CHEMBL5175399

PubChem CID: 168273050

Max Phase: Preclinical

Molecular Formula: C33H53N5O7S3

Molecular Weight: 728.02

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OCC(=O)NCCOCCS(=O)(=O)N1CCC(C(=O)Nc2ncc(SCc3ncc(C(C)(C)C)o3)s2)CC1

Standard InChI:  InChI=1S/C33H53N5O7S3/c1-22(2)25-8-7-23(3)17-26(25)44-20-28(39)34-11-14-43-15-16-48(41,42)38-12-9-24(10-13-38)31(40)37-32-36-19-30(47-32)46-21-29-35-18-27(45-29)33(4,5)6/h18-19,22-26H,7-17,20-21H2,1-6H3,(H,34,39)(H,36,37,40)/t23-,25+,26-/m1/s1

Standard InChI Key:  XDXRGSAFJHMCQW-DMTNHVFBSA-N

Alternative Forms

  1. Parent:

    ALA5175399

    ---

Associated Targets(Human)

CDK9 Tchem Cyclin-dependent kinase 9 (2495 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCNT1 Tchem Cyclin T1 (379 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 728.02Molecular Weight (Monoisotopic): 727.3107AlogP: 5.31#Rotatable Bonds: 16
Polar Surface Area: 152.96Molecular Species: NEUTRALHBA: 11HBD: 2
#RO5 Violations: 3HBA (Lipinski): 12HBD (Lipinski): 2#RO5 Violations (Lipinski): 3
CX Acidic pKa: 7.95CX Basic pKa: 0.54CX LogP: 3.59CX LogD: 3.48
Aromatic Rings: 2Heavy Atoms: 48QED Weighted: 0.17Np Likeness Score: -1.43

References

1. Li J, Liu T, Song Y, Wang M, Liu L, Zhu H, Li Q, Lin J, Jiang H, Chen K, Zhao K, Wang M, Zhou H, Lin H, Luo C..  (2022)  Discovery of Small-Molecule Degraders of the CDK9-Cyclin T1 Complex for Targeting Transcriptional Addiction in Prostate Cancer.,  65  (16.0): [PMID:35925880] [10.1021/acs.jmedchem.2c00257]

Source